miRagen Therapeutics

miRagen Therapeutics

miRagen Therapeutics

miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health.
Suggest edits
Founded
2007
Raised
$60.5M
Follow us
Also headquartered in Boulder
Companies in the same industry
Alexa global traffic share
Twitter followers
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4

Add info
Add round
01 Nov 2016
$40,000,000
Venture capital (Series D)
Atlas Venture, MP Healthcare Venture Management, Fidelity Management and Research Company, +4

Miragen racks up $40 mln, will merge with Signal Genetics

PE Hub
18 Feb 2015
$8,500,000
Venture capital (Series C)
Atlas Venture, Boulder Ventures, Broadview Ventures, +2
03 Jun 2009
$4,000,000
Venture capital (Series B)
Boulder Ventures, Broadview Ventures, The Peierls Foundation, +1
19 May 2008
$8,000,000
Venture capital (Series A)
Atlas Venture, Boulder Ventures